Innovating Biotherapeutics and Diagnostics
Transforming healthcare through CovX-Bodies and advanced diagnostic techniques.
At CovX, we merge the precision of biotechnology with the power of diagnostics to deliver next-generation solutions for medicine, research, and patient care.
About CovX
CovX is a privately-held biotechnology company pioneering the development of CovX-Bodies innovative biotherapeutics that merge the potency of peptides with the stability and clinical advantages of antibodies.
Our mission is to develop long-acting, more effective treatments for patients worldwide.
Our Science: CovX-Bodies Explained
What are CovX-Bodies?
CovX-Bodies are a fusion of a therapeutic peptide with an antibody scaffold.
- The peptide delivers targeted biological activity.
- The antibody ensures long half-life, stability, and delivery efficiency.
Our Vision
At CovX, our mission is to transform healthcare by combining therapeutic innovation with diagnostic excellence.
We develop CovX-Bodies and offer state-of-the-art diagnostic techniques to support laboratories, hospitals, and research centers worldwide.
Products and Solutions
At CovX, we bring together therapeutic innovation and diagnostic excellence to address the most pressing challenges in modern healthcare. Our portfolio is designed not only to advance treatment options but also to provide the diagnostic precision needed for early detection, patient stratification, and personalized medicine.
01
CovX-Bodies (Therapeutics)
- Next-generation long-acting peptide-antibody fusion drugs
- Designed for improved efficacy and patient outcomes
02
Diagnostic Techniques and Kits
- Advanced molecular diagnostics
- Immunoassay and antibody-based testing
- Biomarker detection tools
- Customized diagnostic solutions for clinical and research needs
Diagnostic Techniques and Solutions
In addition to therapeutics, CovX offers a robust diagnostic portfolio, tailored for clinical laboratories, hospitals, and research centers.
01
- PCR-based detection systems
- qPCR and real-time monitoring kits
- Next-generation sequencing (NGS)-ready sample prep
02
Immunoassays and Antibody-Based Tests
- ELISA kits for disease biomarkers
- Rapid immunochromatographic tests
- Antibody panels for research and clinical validation
03
Biomarker Discovery and Detection
- Oncology biomarkers (tumor markers, genetic alterations)
- Infectious disease diagnostics (viral/bacterial detection)
- Autoimmune and inflammatory markers
04
- Tailor-made kits for clinical trials
- Companion diagnostics for CovX-Bodies
- OEM diagnostic partnerships
Pipeline and Research Focus
CovX is advancing a diversified pipeline of CovX-Bodies and diagnostic platforms in multiple therapeutic areas:
Pharmaceutical companies
To co-develop CovX-Bodies and expand clinical indications.
Academic and research institutions
To accelerate translational medicine projects.
Healthcare providers
To integrate companion diagnostics and therapeutics.
Partnership Opportunities
CovX actively seeks strategic collaborations with:
Frequently Asked Questions (FAQ)
Molecular diagnostics includes techniques in biology that allow the detection and analysis of genetic material (DNA/RNA) or proteins to identify diseases, infections, genetic mutations, or specific biomarkers.
CovX develops and provides a wide range of solutions:
- PCR and qPCR kits for pathogen and mutation detection.
- Sample prep solutions for sequencing (NGS).
- Antibody-based immunoassays (ELISA, rapid tests).
- Biomarker detection tools for oncology, immunology, and metabolic diseases.
- Customized solutions for research labs and clinical trials.
Yes . CovX offers tailor-made kits for clinical laboratories, pharmaceutical trials, and research centers.
We collaborate to develop OEM tests, companion diagnostics, and solutions adapted to the specific needs of each partner.